Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
PCSK9i and Prevention of CVD
The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients
This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.
.png/jcr:content/pulmonary-embolism-thumb%20(1).png)
Trends in Pulmonary Embolism-related mortality in Europe
An analysis of vital registration data from the WHO Mortality Database (2000-2015).
-thumb.jpg/jcr:content/lp(a)-thumb.jpg)
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
PCSK9i and Prevention of CVD
The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)
Many associated factors are modifiable indicating potential benefit from planned strategies.
Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery
Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.
ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci
Events
Stay up to date and register for the latest events and view webinar recordings.
